Investing Profile

Dov Goldstein


Photo of Dov Goldstein, Managing Partner at Aisling Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Aisling Capital Managing Partner
CompanyStageDateRound SizeTotal Raised
Loxo Oncology
Series BMay 2014$24M
Series AOct 2013$33M
Co-investors: David Bonita (OrbiMed), Josh Bilenker (Aisling Capital), James Barrett
Esperion Therapeutics
Venture RoundApr 2013$33M
Series AMay 2008$23M
Co-investors: Nicole Vitullo (Domain Associates)